Education
About Us
Working with TipRanks
Follow Us
AlzeCure Pharma AB (SE:ALZCUR)
:ALZCUR
ALZCUR Stock Chart & Stats
kr2.44
kr0.16(7.05%)
At close: 4:00 PM EST
kr2.44
kr0.16(7.05%)
Day’s Range― - ―
52-Week Rangekr0.77 - kr4.95
Previous CloseN/A
Volume72.39K
Average Volume (3M)68.74K
Market Cap
kr252.81M
Enterprise Valuekr228.68M
Total Cash (Recent Filing)kr59.19M
Total Debt (Recent Filing)kr2.83M
Price to Earnings (P/E)―
Beta-0.11
Next Earnings
Feb 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding114,914,450
10 Day Avg. Volume56,724
30 Day Avg. Volume68,736
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)3.36
Price to Sales (P/S)0.00
P/FCF Ratio-2.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ALZCUR FAQ
What was AlzeCure Pharma AB’s price range in the past 12 months?
AlzeCure Pharma AB lowest stock price was kr0.77 and its highest was kr4.95 in the past 12 months.
What is AlzeCure Pharma AB’s market cap?
AlzeCure Pharma AB’s market cap is kr252.81M.
When is AlzeCure Pharma AB’s upcoming earnings report date?
AlzeCure Pharma AB’s upcoming earnings report date is Feb 26, 2026 which is in 72 days.
How were AlzeCure Pharma AB’s earnings last quarter?
AlzeCure Pharma AB released its earnings results on Nov 11, 2025. The company reported -kr0.091 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.091.
Is AlzeCure Pharma AB overvalued?
According to Wall Street analysts AlzeCure Pharma AB’s price is currently Overvalued.
Does AlzeCure Pharma AB pay dividends?
AlzeCure Pharma AB does not currently pay dividends.
What is AlzeCure Pharma AB’s EPS estimate?
AlzeCure Pharma AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AlzeCure Pharma AB have?
AlzeCure Pharma AB has 114,914,450 shares outstanding.
What happened to AlzeCure Pharma AB’s price movement after its last earnings report?
AlzeCure Pharma AB reported an EPS of -kr0.091 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.314%.
Which hedge fund is a major shareholder of AlzeCure Pharma AB?
Currently, no hedge funds are holding shares in SE:ALZCUR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
AlzeCure Pharma AB
AlzeCure Pharma AB (ALZCUR) is a Swedish pharmaceutical company that focuses on developing innovative therapies for neurodegenerative diseases, with a particular emphasis on Alzheimer's disease and pain management. The company operates in the biotechnology sector, leveraging its expertise in neuroscience to advance its pipeline of drug candidates. AlzeCure's core products include a range of proprietary small molecule drugs that target key pathways involved in neurodegeneration.
Technical Analysis
Orexo AB
―
Klaria Pharma Holding AB
―
Nanexa AB
―
Enzymatica AB
―
Enorama Pharma AB
―